Showing results (151-160 of 397) with videos related to
Sort By:
Pageof 40
Clinics and Practice|October 27, 2023
Use of Oral Anticoagulants in Patients with Atrial Fibrillation: Preliminary Data from the Italian Atrial Fibrillation (ITALY-AF) RegistryFabio Angeli, Gianpaolo Reboldi, Giancarlo Agnelli, et al.International Journal of Cardiology|November 26, 2020
Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registryGiuseppe Ciliberti, Monica Verdoia, Marco Merlo, et al.European Heart Journal|April 1, 2006
Left intraventricular myocardial deformation dyssynchrony identifies responders to cardiac resynchronization therapy in patients with heart failureDonato Mele, Giovanni Pasanisi, Fabio Capasso, et al.Clinical Cardiology|January 24, 2018
Clinical and prognostic relationships of pulmonary artery to aorta diameter ratio in patients with heart failure: a cardiac magnetic resonance imaging studyPierpaolo Pellicori, Alessia Urbinati, Jufen Zhang, et al.Cardiac Electrophysiology Clinics|September 24, 2022
Pathophysiology of Typical Atrial FlutterYari Valeri, Giuseppe Bagliani, Paolo Compagnucci, et al.High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|January 31, 2012
Microalbuminuria and left ventricular mass in overweight and obese hypertensive patients: role of the metabolic syndromeFederico Guerra, Lucia Mancinelli, Alessia Buglioni, et al.Plos One|February 10, 2011
The association of left ventricular hypertrophy with metabolic syndrome is dependent on body mass index in hypertensive overweight or obese patientsFederico Guerra, Lucia Mancinelli, Luca Angelini, et al.Cardiac Electrophysiology Clinics|September 24, 2022
Atrial Flutter in Particular Patient PopulationsPaolo Compagnucci, Michela Casella, Giuseppe Bagliani, et al.Journal of Clinical Medicine|April 9, 2024
Arrhythmic Mitral Valve Prolapse and Sports Activity: Pathophysiology, Risk Stratification, and Sports Eligibility AssessmentPaolo Compagnucci, Adelina Selimi, Laura Cipolletta, et al.Cells|February 26, 2026
Mitochondria at the Crossroads of Cardiovascular Disease: Mechanistic Drivers and Emerging Therapeutic StrategiesSonila Alia, Gaia Pedriali, Paolo Compagnucci, et al.Pageof 40